<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" 
	xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>Phys.org: Phys.Org news tagged with: randomized trials</title>
<link>http://phys.org/</link>
<language>en-us</language> 
<description>Phys.org internet news portal provides the latest news on science including: Physics, Nanotechnology, Life Sciences, Space Science, Earth Science, Environment, Health and Medicine.</description>

 <item>
     <title>Peer support offers promise for reducing depression symptoms</title>
   	 <description>Peer support offers promise as an effective, low-cost tool for fighting depression, a new study by the VA Ann Arbor Healthcare System and University of Michigan Health System finds.</description>
     <link>http://phys.org/news217003208.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Tue, 15 Feb 2011 14:40:28 EST</pubDate>
	 <guid isPermaLink="false">news217003208</guid>
	 
</item>
<item>
     <title>Use of low-dose aspirin associated with improved performance of test for detecting colorectal cancer</title>
   	 <description>Use of low-dose aspirin prior to a newer type of fecal occult blood test is associated with a higher sensitivity for detecting advanced colorectal tumors, compared to no aspirin use, according to a study in the December 8 issue of JAMA.</description>
     <link>http://phys.org/news210964844.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Tue, 07 Dec 2010 17:21:06 EST</pubDate>
	 <guid isPermaLink="false">news210964844</guid>
	 
</item>
<item>
     <title>Validity of cost-effectiveness models based on randomized clinical trials</title>
   	 <description>Cost-effectiveness studies are widely used to guide prescribing policy in many countries, as part of health technology assessment programmes. However, a new study published this week in PLoS Medicine by Tjeerd-Pieter van Staa and colleagues suggests that cost-effectiveness analyses based on data from randomized controlled trials may not be realistic enough to accurately inform policy.</description>
     <link>http://phys.org/news179472784.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Tue, 08 Dec 2009 06:10:01 EST</pubDate>
	 <guid isPermaLink="false">news179472784</guid>
	 
</item>
<item>
     <title>Analysis of drug-eluting stents data demonstrates safety, efficacy in on-and-off-label use</title>
   	 <description>The Cardiovascular Research Foundation (CRF) announced that results of the largest meta-analysis to date comparing mortality rates for drug-eluting stents (DES) versus bare metal stents (BMS) were published online June 15 in the journal Circulation. The study also compared the rates of myocardial infarction (MI) and target vessel revascularization (TVR).</description>
     <link>http://phys.org/news164376550.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Tue, 16 Jun 2009 13:09:37 EST</pubDate>
	 <guid isPermaLink="false">news164376550</guid>
	 
</item>


</channel>
</rss>
